Status:
COMPLETED
Interest of Ultrasonography in Electroneuromyography: Single-blind Randomised Controlled Clinical Trial
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Electromyoneurography
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Echo-nerve tracking during an electroneuromyographic (ENMG) examination by identifying the optimal stimulation site would reduce the stimulation intensities delivered to the patient and thus improve t...
Eligibility Criteria
Inclusion
- Patient requiring an electroneuromyogram whose indication allows the application of a standard protocol of examination.
- Patient that has given his/her free and informed consent.
- Patient that signed the consent form.
- Patient with an health insurance plan.
- The patient is at least 18 years old (≥).
- he patient is under 80 years old (≤).
Exclusion
- Patient with symptoms of neuropathy during the screening.
- Patient whose Neurological severity score (NSS) score is ≥ 3.
- Patient whose neurological examination is abnormal and suggestive of neuropathy.
- Patient presenting a pathology that could cause neuropathy (e.g. diabetes, renal failure, etc.).
- Patient already participating in a category 1 research study (Jardé law).
- Patient in an exclusion period determined by another study.
- Patient under the protection of justice, under guardianship or under curatorship.
- Patient refusing to sign the consent form.
- Patient for which it is impossible to provide information about the study.
- Pregnant patient, parturient, or breastfeeding.
Key Trial Info
Start Date :
April 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 11 2020
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT03868189
Start Date
April 4 2019
End Date
June 11 2020
Last Update
December 3 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nîmes University Hospital
Nîmes, France, 30029
2
CHU Nîmes
Nîmes, France